Login

Journal Image
Current Drug Safety
ISSN (Print): 1574-8863
ISSN (Online): 2212-3911
Epub Full Text Article
DOI: 10.2174/1574886309666140428115040      Price:  $95









Clozapine Safety, 40 Years Later

img
Author(s): Michele Raja and Silvia Raja
Abstract:
Clozapine is, and will remain in the coming years, an irreplaceable drug in psychiatry which has elective indication in treatment-resistant schizophrenia, suicide risk in schizophrenia spectrum disorders, aggressiveness or violence in psychiatric patients, psychosis in Parkinson’s disease, prevention and treatment of tardive dyskinesia. Unfortunately, the drug is largely underused for many and serious side effects. Only a good knowledge of these side effects and of the main strategies to prevent their occurrence or minimize their impact can allow overcoming the under-utilization of this valuable therapy.

The article describes the clinical and epidemiological features of the non-motor side effects of clozapine including blood dyscrasias, constipation, diabetes, enuresis, fever, hepatitis, hypersalivation, ileus, myocarditis, nephritis, priapism, seizures, serositis, weight gain and metabolic syndrome. The paper suggests several strategies, supported by scientific evidence, in the management of these side effects. The neuropsychiatric side effects of clozapine are not discussed in this review

Keywords:
Clozapine, schizophrenia, side effects, treatment
Affiliation:
via Prisciano 26, 00136 – Roma, Italy